Jane Street’s Impact BioMedical IBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,944
Closed -$11.3K – 13272
2026
Q2
$11.3K Buy
+1,944
New +$14.5K ﹤0.01% 11291
2026
Q1
– Sell
-1,116
Closed -$7.11K – 13309
2025
Q4
$7.11K Buy
+1,116
New +$7.45K ﹤0.01% 10883
2024
Q4
– Sell
-1,059
Closed -$26.7K – 10858
2024
Q3
$26.7K Buy
+1,059
New +$31.6K ﹤0.01% 9261

Other funds holding IBO

Jane Street's IBO Position: Q3 2026 in Review

Jane Street sold out of Impact BioMedical (IBO) in Q3 2026, closing a stake of 1,944 shares — an estimated $11.3K sold.

Jane Street first reported a position in IBO in Q3 2024 and held it in 3 quarters. The position peaked at $26.7K in Q3 2024. 19 funds tracked by Wall St. Rank hold IBO as of Q3 2026.

  • Jane Street reported no remaining Impact BioMedical position as of Q3 2026 after selling out during the quarter.
  • Jane Street sold 1,944 Impact BioMedical shares in Q3 2026, an estimated $11.3K.
  • Jane Street first reported a position in Impact BioMedical in Q3 2024 and held it in 3 quarters.
  • Jane Street's Impact BioMedical position peaked at $26.7K in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.